Page last updated: 2024-08-21

thiazoles and neuropeptide y

thiazoles has been researched along with neuropeptide y in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (28.57)18.2507
2000's8 (57.14)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cunningham, AM; Hipkiss, AR; Mayer, S; Michaelis, J; Müller, R; Münch, G; Neumann, A; Riederer, P; Schinzel, R1
Bing, C; Buckingham, R; Dryden, S; Frankish, HM; Hopkins, D; Pickavance, L; Wang, Q; Williams, G1
Alonso, R; Arnone, M; Bignon, E; Boigegrain, R; Brodin, R; Gueudet, C; Héaulme, M; Keane, P; Landi, M; Le Fur, G; Maffrand, JP; Molimard, JC; Olliero, D; Pascal, M; Poncelet, M; Seban, E; Simiand, J; Soubrié, P1
Fukami, T; Fukuroda, T; Hata, M; Ihara, M; Ishihara, A; Kanatani, A; Kanno, T; Mase, T; Sakuraba, A; Tanaka, T; Tsuchiya, Y1
Gruenewald, DA; Marck, BT; Matsumoto, AM; Naai, MA; Wolden-Hanson, T1
Buckingham, RE; Pickavance, LC; Wilding, JP1
Marck, BT; Matsumoto, AM; Wolden-Hanson, T1
Li, M; Lin, Y; Ma, Y; Zheng, Z1
Beck-Sickinger, A; Demuth, H; Dimitrijević, M; Kovacević-Jovanović, V; Stanojević, S; von Hörsten, S; Vujić, V1
Dautzenberg, FM; Guba, W; Higelin, J; Neidhart, W; Pflieger, P1
Demuth, HU; Li, L; Zukowska, Z1
Adams-Deutsch, T; Heilig, M; Nair, SG; Navarre, BM; Pickens, CL; Shaham, Y1
Irwin, CR; Killough, SA; Lundy, FT1
Davies, GE; Fahmy, H; Hu, Y; Kuppast, B; Liapakis, G; Lynch, C; Spyridaki, K1

Reviews

1 review(s) available for thiazoles and neuropeptide y

ArticleYear
Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y.
    Advances in experimental medicine and biology, 2006, Volume: 575

    Topics: Atherosclerosis; Blood Vessels; Dipeptidyl Peptidase 4; Humans; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Neuropeptide Y; Pentanoic Acids; Serine Proteinase Inhibitors; Thiazoles; Thiazolidines; Vasoconstriction

2006

Trials

1 trial(s) available for thiazoles and neuropeptide y

ArticleYear
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
    Zhonghua fu chan ke za zhi, 2002, Volume: 37, Issue:5

    Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome

2002

Other Studies

12 other study(ies) available for thiazoles and neuropeptide y

ArticleYear
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.
    Biochimica et biophysica acta, 1997, Feb-27, Volume: 1360, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Carnosine; Cognition; Cross-Linking Reagents; Fructose; Glycation End Products, Advanced; Guanidines; Humans; Memory; Neuropeptide Y; Particle Size; Peptide Fragments; Piperazines; Protein Structure, Secondary; Solubility; Temperature; Thiazoles; Thiophenes

1997
Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.
    British journal of pharmacology, 1997, Volume: 122, Issue:7

    Topics: Animals; Appetite Stimulants; Body Weight; Eating; Hyperphagia; Hypoglycemic Agents; Hypothalamus; Leptin; Male; Neuropeptide Y; Proteins; Rats; Rats, Wistar; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones

1997
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: Animals; Appetite Stimulants; Callithrix; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Eating; Female; Gallbladder Emptying; Gastric Acid; Gastric Emptying; Gerbillinae; Indoles; Male; Mice; Motor Activity; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Species Specificity; Stereotyped Behavior; Thiazoles

1999
The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Biochemical and biophysical research communications, 1999, Dec-09, Volume: 266, Issue:1

    Topics: Administration, Oral; Animals; Binding, Competitive; Biological Availability; Brain; Carbamates; Cell Membrane; CHO Cells; Cricetinae; Feeding Behavior; Hippocampus; Humans; Inhibitory Concentration 50; Injections, Intraventricular; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Neuropeptide Y; Thiazoles; Time Factors

1999
Aging and the neuroendocrine regulation of reproduction and body weight.
    Experimental gerontology, 2000, Volume: 35, Issue:9-10

    Topics: Aging; Animals; Arcuate Nucleus of Hypothalamus; Body Composition; Body Weight; Chromans; Eating; Gene Expression Regulation, Developmental; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypoglycemic Agents; Insulin; Leptin; Male; Models, Animal; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Rats; Rats, Inbred BN; Reproduction; RNA, Messenger; Testis; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain

2000
Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.
    Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:3

    Topics: Animals; Body Weight; Carrier Proteins; Eating; Food Deprivation; Hyperphagia; Hypoglycemic Agents; Hypothalamus; Insulin Resistance; Ion Channels; Leptin; Male; Mitochondrial Proteins; Neuropeptide Y; Obesity; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Uncoupling Protein 3

2001
Troglitazone treatment of aging Brown Norway rats improves food intake and weight gain after fasting without increasing hypothalamic NPY gene expression.
    Experimental gerontology, 2002, Volume: 37, Issue:5

    Topics: Aging; Animals; Body Composition; Chromans; Eating; Fasting; Gene Expression; Hypoglycemic Agents; Hypothalamus; In Situ Hybridization; Insulin; Leptin; Male; Neuropeptide Y; Protein Precursors; Rats; Rats, Inbred BN; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain

2002
Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
    Journal of neuroimmunology, 2002, Volume: 129, Issue:1-2

    Topics: Animals; Arginine; Cells, Cultured; Concanavalin A; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Edema; Hydrogen Peroxide; Inflammation; Isoleucine; Macrophages; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thiazoles

2002
Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
    Neuropharmacology, 2005, Volume: 48, Issue:7

    Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Mice; Neuropeptide Y; Nitriles; Protein Binding; Receptors, Neuropeptide Y; Thiazoles

2005
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
    Neuroscience, 2009, Dec-29, Volume: 164, Issue:4

    Topics: Acoustic Stimulation; Animals; Arginine; Benzazepines; Conditioning, Operant; Corticotropin-Releasing Hormone; Fear; Male; Neuropeptide Y; Pyridazines; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y; Synaptic Transmission; Thiazoles; Time Factors

2009
Dental pulp fibroblasts express neuropeptide Y Y1 receptor but not neuropeptide Y.
    International endodontic journal, 2010, Volume: 43, Issue:10

    Topics: Blotting, Western; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Coloring Agents; Dental Caries; Dental Pulp; Fibroblasts; Humans; Interleukin-1beta; Membrane Proteins; Neuroimmunomodulation; Neuropeptide Y; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Substance P; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta

2010
Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2014, Volume: 11, Issue:1

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Binding Sites; Corticotropin-Releasing Hormone; Cyclic AMP Response Element-Binding Protein; Dopamine beta-Hydroxylase; Dopamine Plasma Membrane Transport Proteins; Gene Expression; HEK293 Cells; Humans; Monoamine Oxidase; Neuropeptide Y; Protein Binding; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thiazoles

2014